The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of dose reduction on survival in patients starting sunitinib (SU) or pazopanib (PA) as first-line for metastatic renal cell carcinoma (mRCC).
 
Roberto Iacovelli
No Relationships to Disclose
 
Lisa Derosa
No Relationships to Disclose
 
Francesco Massari
No Relationships to Disclose
 
Elena Verri
No Relationships to Disclose
 
Luca Galli
No Relationships to Disclose
 
Chiara Ciccarese
No Relationships to Disclose
 
Maria Cossu Rocca
No Relationships to Disclose
 
Claudia Cianci
No Relationships to Disclose
 
Davide Bimbatti
No Relationships to Disclose
 
Gaetano Aurilio
No Relationships to Disclose
 
Andrea Antonuzzo
No Relationships to Disclose
 
Emanuela Fantinel
No Relationships to Disclose
 
Daniela Cullura
No Relationships to Disclose
 
Sergio Ricci
No Relationships to Disclose
 
Alessandra Modena
No Relationships to Disclose
 
Alfredo Falcone
No Relationships to Disclose
 
Giampaolo Tortora
No Relationships to Disclose
 
Franco Nole
No Relationships to Disclose